A detailed history of Hcr Wealth Advisors transactions in Novo Nordisk A S stock. As of the latest transaction made, Hcr Wealth Advisors holds 11,954 shares of NVO stock, worth $1.04 Million. This represents 0.19% of its overall portfolio holdings.

Number of Shares
11,954
Previous 8,727 36.98%
Holding current value
$1.04 Million
Previous $1.25 Million 14.3%
% of portfolio
0.19%
Previous 0.18%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 10, 2024

BUY
$119.07 - $145.42 $384,238 - $469,270
3,227 Added 36.98%
11,954 $1.42 Million
Q2 2024

Aug 06, 2024

BUY
$122.71 - $146.91 $166,640 - $199,503
1,358 Added 18.43%
8,727 $1.25 Million
Q1 2024

May 10, 2024

BUY
$102.11 - $135.92 $752,448 - $1 Million
7,369 New
7,369 $946,000

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $197B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Hcr Wealth Advisors Portfolio

Follow Hcr Wealth Advisors and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hcr Wealth Advisors, based on Form 13F filings with the SEC.

News

Stay updated on Hcr Wealth Advisors with notifications on news.